✦ LIBER ✦
Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg
✍ Scribed by John R. Zalcberg; Jaap Verweij; Paolo G. Casali; Axel Le Cesne; Peter Reichardt; Jean-Yves Blay; Marcus Schlemmer; Martine Van Glabbeke; Michelle Brown; Ian R. Judson
- Book ID
- 116428607
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 128 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.